Somatostatin in inflammatory bowel disease
Intestinal inflammation is controlled by various immunomodulating cells, interacting by molecular mediators. Neuropeptides, released by enteric nerve cells and neuroendocrine mucosa cells, are able to affect several aspects of the general and intestinal immune system, with both pro- as well as anti-...
Saved in:
Main Authors: | J. D. Van Bergeijk, J. H. P. Wilson |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
1997-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1080/09629359791424 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Absence of Effect of Somatostatin Analogue (SMS 201-995) in Diarrhea Associated with Inflammatory Bowel Disease
by: Richard N. Fedorak, et al.
Published: (1989-01-01) -
Antitumoral and Anti-inflammatory Roles of Somatostatin and Its Analogs in Hepatocellular Carcinoma
by: Argyrios Periferakis, et al.
Published: (2021-01-01) -
Leukocyte migration in experimental inflammatory bowel disease
by: E. P. Van Rees, et al.
Published: (1997-01-01) -
Cytokines in inflammatory bowel disease
by: P. L. Beck, et al.
Published: (1997-01-01) -
The effect of malotilate, a derivative of malotilate and a flavenoid on eicosanoid production in inflammatory bowel disease in rats
by: A. P. M. van Dijk, et al.
Published: (1993-01-01)